Glaxosmithkline Pharmaceuticals Limited v. Cgx Healthcare and Ors.
Case brief
What is this about?
Trademark infringement/passing off; CALPOL v. CALCIPOL-D; GlaxoSmithKline Pharmaceuticals Ltd. v. CGX Healthcare and Ors; CS(COMM) 713/2024; I.A. No. 4054/2025; Delhi High Court; Mini Pushkarna, J.; decree under Order VIII Rule 10 CPC without trial; written statement beyond statutory period; right to file written statement closed; categorical admissions of non-use and closure of business; withdrawal of trade mark application no. 5964176; Trade Marks Registry directions; costs Rs. 1,00,000/-; commercial suit; Commercial Courts Act 2015; 2018 SCC OnLine Del 11666; (2016) 235 DLT 354; consent decree.
What did the court decide?
Suit decreed in favour of the plaintiff against the defendants in terms of Para 56 (a), (b), (c), (d) and (f) of the plaint; defendants directed to withdraw trade mark application no. 5964176 for CALCIPOL-D or any identical/deceptively similar mark, with the Trade Marks Registry to act expeditiously; costs of Rs. 1,00,000/- payable jointly by defendant nos. 1 to 4 and Rs. 1,00,000/- by defendant no. 5, within four months; suit and pending application (I.A. No. 4054/2025) disposed of; next hearing date of 07.05.2025 cancelled.